Research use only. All compounds are for in vitro laboratory research. Not for human consumption. Not FDA approved.
SLU-PP-332
HPLC Verified
>99% Purity
COA Included
Metabolic Research Peptides

SLU-PP-332

$48.00
SLU-PP-332 — synthetic ERR agonist studied for mitochondrial biogenesis and metabolic regulation. >99% HPLC purity. Third-party COA included. US domestic shipping.
Format Lyophilized powder
Purity >99% HPLC verified
Storage Lyophilized: -20°C
CAS Number
Select Size
Also available: Semaglutide →
In Stock — 2–5 day domestic delivery
HPLC Verified
>99% Purity
📄 COA Included
For Research Use Only (RUO)
Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease. For in vitro and laboratory research purposes only.
SLU-PP-332 $48.00

Product Information

Why Buy SLU-PP-332 from Official Peptides

Official Peptides supplies research-grade SLU-PP-332 to US researchers with >99% HPLC purity and third-party COA on every batch. SLU-PP-332 is a novel synthetic small-molecule compound studied for mitochondrial activation and metabolic regulation. US domestic shipping 2-5 business days. For in vitro research use only.

SLU-PP-332 Research Profile

SLU-PP-332 is a synthetic small-molecule agonist of estrogen-related receptors (ERR-alpha, ERR-beta, ERR-gamma) that has been studied in research models of mitochondrial biogenesis, oxidative metabolism, and exercise mimetics. It activates the same transcriptional pathways as endurance exercise in preclinical models, making it a significant tool compound in metabolic and mitochondrial research. Unlike peptide-based compounds, SLU-PP-332 is produced through chemical synthesis and is intended for analytical and mechanistic investigation in non-clinical research settings. Molecular weight: 418.5 g/mol.

Product Specifications

  • Purity: >99% HPLC verified
  • Format: Lyophilized powder
  • Available sizes: 5mg, 10mg, 20mg per vial
  • Storage: -20C, protect from moisture and light
  • Shipping: US domestic 2-5 business days
  • Certificate of Analysis: Included with every order

Frequently Asked Questions

Q: What is SLU-PP-332 studied for in research?
A: SLU-PP-332 is investigated in metabolic research models examining ERR agonism, mitochondrial biogenesis, oxidative phosphorylation, and exercise-mimetic pathways. It is a key tool compound in metabolic and longevity research. For research use only.

Q: How does SLU-PP-332 work in research models?
A: SLU-PP-332 activates estrogen-related receptors (ERR-alpha, beta, gamma), upregulating genes involved in mitochondrial biogenesis and fatty acid oxidation – the same pathways activated by endurance exercise in preclinical models.

Q: What purity does Official Peptides supply for SLU-PP-332?
A: All SLU-PP-332 from Official Peptides is third-party HPLC-verified at >99% purity with a batch-specific COA included with every order.

Order SLU-PP-332 Online

Buy research-grade SLU-PP-332 from Official Peptides with same-week US dispatch. Every vial ships with a third-party HPLC-verified COA. Add to cart above or contact us for bulk pricing.

For Research Use Only. This compound is intended strictly for in vitro laboratory research by qualified scientists. Not for human consumption. Not FDA approved. Keep out of reach of children.

Third-Party Verified

Every Order Ships with a Certificate of Analysis

We don't just claim purity — we prove it. Every batch of SLU-PP-332 is independently tested by an accredited third-party laboratory before it reaches you. Your COA is linked to your specific lot number.

HPLC purity analysis — minimum threshold >99%
Mass spectrometry — molecular weight confirmation
Lot number traceable to your order
Endotoxin limits verified — safe for cell-based assays
View Sample COA & Testing Process
Official Peptides Labs Certificate of Analysis
ProductSLU-PP-332
Lot #OP-2025-6481
HPLC Purity>99.0%99.2%PASS
Mass Spec (MW)ConfirmedConfirmedPASS
Endotoxin<1 EU/mg<0.5 EU/mgPASS

Researcher Reviews

Reviews

There are no reviews yet.

Be the first to review “SLU-PP-332”

Your email address will not be published. Required fields are marked *